Express News | Tang Capital Management, LLC Reports 9.7% Stake in ESSA Pharma as of Nov 1- SEC Filing
ESSA Pharma(EPIX.US) 10% Shareholder Sells US$12.02 Million in Common Stock
ESSA Pharma Slides As Insider Purchases Lose Another US$211k
ESSA Pharma Downgraded by Oppenheimer, Piper Sandler After Drug Setback in Trials
Express News | ESSA Pharma Shares Are Trading Lower After Oppenheimer Downgraded the Stock From Outperform to Perform. Piper Sandler Downgraded Its Rating From Overweight to Neutral and Cut Its Price Target From $15 to $2
Essa Pharma Price Target Cut to $2.00/Share From $15.00 by Piper Sandler
